The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma von Hammons, Lindsay, Szabo, Aniko, Janardan, Abhishek, Bhatlapenumarthi, Vineel, Annyapu, Evanka, Dhakal, Binod, Al Hadidi, Samer, Radhakrishnan, Sabarinath Venniyil, Narra, Ravi, Bhutani, Divaya, Thanendrarajan, Sharmilan, Janz, Siegfried, Zangari, Maurizio, Lentzsch, Suzanne, Van Rhee, Frits, Crescencio, Juan Carlos Rico, D'Souza, Anita, Chakraborty, Rajshekhar, Mohan, Meera, Schinke, Carolina

Volltext

Novel anti-myeloma immunotherapies targeting the SLAM family of receptors von Radhakrishnan, Sabarinath Venniyil, Bhardwaj, Neelam, Luetkens, Tim, Atanackovic, Djordje

Volltext

Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study von Gong, Zimu, Umoru, Godsfavour, Monge, Jorge, Shah, Nishi, Mohyuddin, Ghulam Rehman, Radhakrishnan, Sabarinath Venniyil, Chakraborty, Rajshekhar, Rasche, Leo, Schinke, Carolina, D’Souza, Anita, Mohan, Meera

Volltext

Elotuzumab as a novel anti-myeloma immunotherapy von Radhakrishnan, Sabarinath Venniyil, Bhardwaj, Neelam, Steinbach, Mary, Weidner, Janet, Luetkens, Tim, Atanackovic, Djordje

Volltext

Murine cytomegalovirus immediate-early 1 gene expression correlates with increased GVHD after allogeneic hematopoietic cell transplantation in recipients reactivating from latent i... von Palaniyandi, Senthilnathan, Radhakrishnan, Sabarinath Venniyil, Karlsson, Fridrik J, Stokes, Karen Y, Kittan, Nicolai, Huber, Elisabeth, Hildebrandt, Gerhard C

Volltext

The role of surface molecule CD229 in Multiple Myeloma von Olson, Michael, Radhakrishnan, Sabarinath Venniyil, Luetkens, Tim, Atanackovic, Djordje

Volltext

Kinetics of humoral immunodeficiency with bispecific antibody therapy in multiple myeloma von Hammons, Lindsay, Szabo, Aniko, Dhakal, Binod, Venniyil Radhakrishnan, Sabarinath, Chhabra, Saurabh, D'Souza, Anita, Mohan, Meera

Volltext

Engineering anti-CD229 CAR T cell selectivity for multiple myeloma von Baker, Jillian, Radhakrishnan, Sabarinath Venniyil, Olson, Michael, Atanackovic, Djordje, Luetkens, Tim, Mause, Erica Vander

Volltext

Risk of infections with B-cell maturation antigen-directed immunotherapy in multiple myeloma von Mohan, Meera, Nagavally, Sneha, Dhakal, Binod, Radhakrishnan, Sabarinath Venniyil, Chhabra, Saurabh, D'Souza, Anita, Hari, Parameswaran

Volltext

Immunotherapies targeting CD38 in Multiple Myeloma von Atanackovic, Djordje, Steinbach, Mary, Radhakrishnan, Sabarinath Venniyil, Luetkens, Tim

Volltext

In vivo vaccination effect in multiple myeloma patients treated with the monoclonal antibody isatuximab von Atanackovic, Djordje, Yousef, Sara, Shorter, Christa, Tantravahi, Srinivas K., Steinbach, Mary, Iglesias, Fiorella, Sborov, Douglas, Radhakrishnan, Sabarinath Venniyil, Chiron, Marielle, Miles, Rodney, Salama, Mohamed, Kröger, Nicolaus, Luetkens, Tim

Volltext

Abstract 3774: A high-throughput process for the development and characterization of chimeric antigen receptors (CARs) von Radhakrishnan, Sabarinath Venniyil, Miles, Adam, Atanackovic, Djordje, Luetkens, Tim

Volltext

Blood and marrow transplant within 4 weeks of SARS-CoV-2 infection is associated with increased risk of mortality: a National COVID Cohort Collaborative (N3C) Study von Mohan, Meera, Kothari, Anai, Verhagen, Nathaniel, Shreenivas, Aditya, Radhakrishnan, Sabarinath Venniyil, Dhakal, Binod, Figueroa-Castro, Carlos, Chhabra, Saurabh, Janz, Siegfried, Pasquini, Marcello, Hamadani, Mehdi, Szabo, Aniko, D’Souza, Anita

Volltext

Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy von Al Hadidi, Samer, Szabo, Aniko, Esselmann, Jean, Hammons, Lindsay, Hussain, Munawwar, Ogunsesan, Yetunde, Thalambedu, Nishanth, Khan, Fatima, Sethi, Jaskirat, Janardan, Abhishek, Radhakrishnan, Sabarinath Venniyil, Thanendrarajan, Sharmilan, Schinke, Carolina, Dhakal, Binod, Janz, Siegfried, Chhabra, Saurabh, D’Souza, Anita, Zangari, Maurizio, van Rhee, Frits, Mohan, Meera

Volltext

Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple m... von Mohan, Meera, Szabo, Aniko, Patwari, Anannya, Esselmann, Jean, Patel, Tanvi, Bachu, Ramya, Rein, Lisa E., Janardan, Abhishek, Bhatlapenumarthi, Vineel, Annyapu, Evanka, Skoog, Catherine, Goff, Areyl, Hadidi, Samer Al, Radhakrishnan, Sabarinath Venniyil, Thanendrarajan, Sharmilan, Zangari, Maurizio, Shah, Nirav, van Rhee, Frits, Dhakal, Binod, Hamadani, Mehdi, D’Souza, Anita, Schinke, Carolina

Volltext

Dimethyl Oxalyl Glycine a Prolyl Hydroxylase Inhibitor Decreases Early Gastrointestinal Gvhd Via Two Independent Pathways of Apoptosis after Allogeneic Hematopoietic Cell Transplan... von Kumari, Reena, Palaniyandi, Senthilnathan, Strattan, Ethan, Venniyil Radhakrishnan, Sabarinath, Hildebrandt, Gerhard Carl

Volltext

The Effect of Stem Cell Infusion on Immune Effector Cell Associated Hematotoxicity with BCMA CAR T in Multiple Myeloma von Patwari, Anannya, Patel, Tanvi H., Bachu, Ramya, Esselmann, Jean, Rein, Lisa, Szabo, Aniko, Janardan, Abhishek, Bhatlapenumarthi, Vineel, Annyapu, Evanka, Skoog, Catherine E., Goff, Areyl, Al Hadidi, Samer, Venniyil Radhakrishnan, Sabarinath, Thanendrarajan, Sharmilan, Zangari, Maurizio, van Rhee, Frits, Dhakal, Binod, D'Souza, Anita, Mohan, Meera, Schinke, Carolina

Volltext

Changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody therapy in patients with relapsed refractory multiple myeloma (RRMM) von Janardan, Abhishek, Lindsay, Hammons, Szabo, Aniko, Bhatlapenumarthi, Vineel, Annyapu, Evanka, Dhakal, Binod, Narra, Ravi Kishore, Al Hadidi, Samer, Venniyil Radhakrishnan, Sabarinath, Bhutani, Divaya, Thanendrarajan, Sharmilan, Siegfried, Janz, Zangari, Maurizio, Lentzsch, Suzanne, van Rhee, Frits, D'Souza, Anita, Chakraborty, Rajshekhar, Schinke, Carolina D., Mohan, Meera

Volltext

Corneal toxicity with belantamab mafodotin: Multi‐institutional real‐life experience von Mohan, Meera, Rein, Lisa E., Thalambedu, Nishanth, Ogunsesan, Yetunde, Hussain, Munawwar, Sethi, Jaskirat, Khan, Fatima, Gundarlapalli, Sravani, Yarlagadda, Lakshmi, Dhakal, Binod, Price, Mary, Shirey, Megan, Warner, Davie, Thanendrarajan, Sharmilan, Janz, Siegfried, Radhakrishnan, Sabarinath Venniyil, Al Hadidi, Samer, Szabo, Aniko, D'Souza, Anita, Zangari, Maurizio, Rhee, Frits, Chhabra, Saurabh, Schinke, Carolina

Volltext

Oscillating expression of interleukin-16 in multiple myeloma is associated with proliferation, clonogenic growth, and PI3K/NFKB/MAPK activation von Templin, Julia, Atanackovic, Djordje, Hasche, Daniel, Radhakrishnan, Sabarinath Venniyil, Luetkens, Tim

Volltext